Deoxyribonucleic Acid (DNA) Profiling Kits Market Report 2026

The deoxyribonucleic acid (DNA) profiling kits market size has grown rapidly in recent years. It will grow from $1.4 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to growth in forensic science applications in law enforcement, expansion of paternity and kinship testing services, increasing adoption of polymerase chain reaction technology in laboratories, rising government investment in forensic infrastructure, development of standardized dna testing protocols in clinical research.

The deoxyribonucleic acid (DNA) profiling kits market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion by 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to advancement in next generation sequencing technologies, increasing demand for personalized medicine and genetic diagnostics, integration of ai driven genetic data interpretation tools, expansion of direct to consumer genetic testing markets, rising adoption of automated high throughput dna analysis systems. Major trends in the forecast period include increasing adoption of next generation sequencing based dna profiling kits for high accuracy genetic analysis, growing demand for rapid forensic dna testing kits in criminal investigation workflows, rising use of automated dna extraction and amplification systems in laboratories, expansion of direct to consumer genetic testing kit adoption for ancestry and relationship mapping, increasing integration of cloud based dna data analysis platforms for secure genetic data management.

The rising demand for personalized medicine is expected to propel the growth of the deoxyribonucleic acid (DNA) profiling kits market going forward. Personalized medicine refers to a medical approach that utilizes an individual’s genetic profile to guide decisions associated with the prevention, diagnosis, and treatment of diseases. The demand for personalized medicine is increasing due to the growing need for targeted therapies that enhance treatment effectiveness and reduce adverse drug reactions. The deoxyribonucleic acid (DNA) profiling kits support and contribute to personalized medicine by enabling precise genetic analysis, which assists healthcare providers in tailoring treatments based on individual genetic variations. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant rise compared to six approvals in 2022. Therefore, the rising demand for personalized medicine is propelling the growth of the deoxyribonucleic acid (DNA) profiling kits market.

Leading companies operating in the deoxyribonucleic acid (DNA) profiling kits market are focusing on advancements in polymerase chain reaction techniques, such as enhanced multiplex PCR amplification systems, to improve sensitivity, accuracy, and efficiency in DNA profiling workflows. Enhanced multiplex PCR amplification systems are advanced technologies that enable the simultaneous amplification of multiple DNA targets in a single reaction, allowing forensic laboratories to generate comprehensive genetic profiles from low-quality or degraded samples while reducing processing time and reagent usage. For example, in January 2023, Promega Corporation, a US-based biotechnology company, launched the PowerPlex Fusion 6C System. This advanced STR analysis kit features expanded loci coverage for improved discrimination power, incorporates high-sensitivity chemistry for challenging forensic samples, and supports direct amplification from casework samples, thereby reducing preparation steps and turnaround time. These innovations enhance the reliability of forensic investigations and improve laboratory throughput.

In January 2023, QIAGEN N. V., a Netherlands-based molecular diagnostics company, acquired Verogen Inc. for $150 million. Through this acquisition, QIAGEN seeks to reinforce its position in human identification and forensic genomics by broadening its next-generation sequencing capabilities and improving end-to-end DNA analysis workflows. Verogen Inc. is a US-based provider of DNA-based human identification solutions, including sequencing kits and forensic analysis platforms.

Major companies operating in the deoxyribonucleic acid (dna) profiling kits market are Thermo Fisher Scientific Inc., Danaher Corporation, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Endress+Hauser AG, Bio-Rad Laboratories Inc., QIAGEN N. V., Kurabo Industries Ltd., Promega Corporation, Takara Bio Inc., Bioneer Corporation, New England Biolabs Inc., Omega Bio-tek Inc., Zymo Research Corporation, ANDE Corporation, GeneReach Biotechnology Corp., Norgen Biotek Corp., AutoGen Inc., Zinexts Life Science Corp., Living DNA Ltd., Wyndham Forensic Group Ltd.

North America was the largest region in the deoxyribonucleic acid profiling kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (DNA) profiling kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the deoxyribonucleic acid (DNA) profiling kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deoxyribonucleic acid (DNA) profiling kits market consists of sales of forensic DNA profiling kits, paternity testing kits, ancestry DNA kits, short tandem repeat analysis kits, and rapid DNA testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.